INFO:
See Full Prescribing Information for OPDIVO Qvantig at bit.ly/OPDIVOQvantigPI. Review the clinical data supporting subcutaneous nivolumab and hyaluronidase-nvhy in earlier stages of cancer and consider this immunotherapy for eligible patients.
Discover OPDIVO Qvantig | OPDIVO Qvantig™ (nivolumab + hyaluronidase-nvhy) US HCP